These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 19181347

  • 1. White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis.
    Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, Inglese M.
    J Neurol Sci; 2009 Jul 15; 282(1-2):28-33. PubMed ID: 19181347
    [Abstract] [Full Text] [Related]

  • 2. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter.
    Law M, Saindane AM, Ge Y, Babb JS, Johnson G, Mannon LJ, Herbert J, Grossman RI.
    Radiology; 2004 Jun 15; 231(3):645-52. PubMed ID: 15163806
    [Abstract] [Full Text] [Related]

  • 3. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T.
    Adhya S, Johnson G, Herbert J, Jaggi H, Babb JS, Grossman RI, Inglese M.
    Neuroimage; 2006 Dec 15; 33(4):1029-35. PubMed ID: 16996280
    [Abstract] [Full Text] [Related]

  • 4. Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.
    Ingrisch M, Sourbron S, Herberich S, Schneider MJ, Kümpfel T, Hohlfeld R, Reiser MF, Ertl-Wagner B.
    Invest Radiol; 2017 Mar 15; 52(3):135-141. PubMed ID: 27548346
    [Abstract] [Full Text] [Related]

  • 5. The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis.
    Griffin CM, Chard DT, Parker GJ, Barker GJ, Thompson AJ, Miller DH.
    J Neurol; 2002 Feb 15; 249(2):193-9. PubMed ID: 11985386
    [Abstract] [Full Text] [Related]

  • 6. White matter and deep gray matter hemodynamic changes in multiple sclerosis patients with clinically isolated syndrome.
    Papadaki EZ, Mastorodemos VC, Amanakis EZ, Tsekouras KC, Papadakis AE, Tsavalas ND, Simos PG, Karantanas AH, Plaitakis A, Maris TG.
    Magn Reson Med; 2012 Dec 15; 68(6):1932-42. PubMed ID: 22367604
    [Abstract] [Full Text] [Related]

  • 7. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    Hojjat SP, Kincal M, Vitorino R, Cantrell CG, Feinstein A, Zhang L, Lee L, O'Connor P, Carroll TJ, Aviv RI.
    AJNR Am J Neuroradiol; 2016 Aug 15; 37(8):1454-61. PubMed ID: 27012299
    [Abstract] [Full Text] [Related]

  • 8. Myelin content changes in Clinically Isolated Syndrome and Relapsing- Remitting Multiple Sclerosis: Associations with lesion type and severity of visuomotor impairment.
    Panou Τ, Kavroulakis E, Mastorodemos V, Pouli S, Kalaitzakis G, Spyridaki E, Maris TG, Simos P, Papadaki E.
    Mult Scler Relat Disord; 2021 Sep 15; 54():103108. PubMed ID: 34198031
    [Abstract] [Full Text] [Related]

  • 9. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis.
    Inglese M, Adhya S, Johnson G, Babb JS, Miles L, Jaggi H, Herbert J, Grossman RI.
    J Cereb Blood Flow Metab; 2008 Jan 15; 28(1):164-71. PubMed ID: 17473851
    [Abstract] [Full Text] [Related]

  • 10. Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
    Lund H, Krakauer M, Skimminge A, Sellebjerg F, Garde E, Siebner HR, Paulson OB, Hesse D, Hanson LG.
    PLoS One; 2013 Jan 15; 8(2):e56375. PubMed ID: 23441184
    [Abstract] [Full Text] [Related]

  • 11. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T.
    Inglese M, Park SJ, Johnson G, Babb JS, Miles L, Jaggi H, Herbert J, Grossman RI.
    Arch Neurol; 2007 Feb 15; 64(2):196-202. PubMed ID: 17296835
    [Abstract] [Full Text] [Related]

  • 12. Brain macro- and microscopic damage in patients with paediatric MS.
    Absinta M, Rocca MA, Moiola L, Ghezzi A, Milani N, Veggiotti P, Comi G, Filippi M.
    J Neurol Neurosurg Psychiatry; 2010 Dec 15; 81(12):1357-62. PubMed ID: 20660915
    [Abstract] [Full Text] [Related]

  • 13. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis.
    Davies GR, Altmann DR, Hadjiprocopis A, Rashid W, Chard DT, Griffin CM, Tofts PS, Barker GJ, Kapoor R, Thompson AJ, Miller DH.
    J Neurol; 2005 Sep 15; 252(9):1037-44. PubMed ID: 15834645
    [Abstract] [Full Text] [Related]

  • 14. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity.
    Ge Y, Law M, Johnson G, Herbert J, Babb JS, Mannon LJ, Grossman RI.
    AJNR Am J Neuroradiol; 2005 Sep 15; 26(6):1539-47. PubMed ID: 15956527
    [Abstract] [Full Text] [Related]

  • 15. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
    Vrenken H, Pouwels PJ, Ropele S, Knol DL, Geurts JJ, Polman CH, Barkhof F, Castelijns JA.
    Mult Scler; 2007 Jul 15; 13(6):708-16. PubMed ID: 17613597
    [Abstract] [Full Text] [Related]

  • 16. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T.
    Ingrisch M, Sourbron S, Morhard D, Ertl-Wagner B, Kümpfel T, Hohlfeld R, Reiser M, Glaser C.
    Invest Radiol; 2012 Apr 15; 47(4):252-8. PubMed ID: 22373532
    [Abstract] [Full Text] [Related]

  • 17. Cerebral white matter blood flow and energy metabolism in multiple sclerosis.
    Steen C, D'haeseleer M, Hoogduin JM, Fierens Y, Cambron M, Mostert JP, Heersema DJ, Koch MW, De Keyser J.
    Mult Scler; 2013 Sep 15; 19(10):1282-9. PubMed ID: 23428956
    [Abstract] [Full Text] [Related]

  • 18. A comparative assessment of cerebral white matter by magnetization transfer imaging in early- and adult-onset multiple sclerosis patients matched for disease duration.
    Oguz KK, Kurne A, Aksu AO, Taskiran A, Karabulut E, Karabudak R.
    J Neurol; 2010 Aug 15; 257(8):1309-15. PubMed ID: 20221767
    [Abstract] [Full Text] [Related]

  • 19. Regional MRI perfusion measures predict motor/executive function in patients with clinically isolated syndrome.
    Papadaki EZ, Simos PG, Mastorodemos VC, Panou T, Maris TG, Karantanas AH, Plaitakis A.
    Behav Neurol; 2014 Aug 15; 2014():252419. PubMed ID: 24825950
    [Abstract] [Full Text] [Related]

  • 20. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
    Ramasamy DP, Benedict RH, Cox JL, Fritz D, Abdelrahman N, Hussein S, Minagar A, Dwyer MG, Zivadinov R.
    J Neurol Sci; 2009 Jul 15; 282(1-2):47-54. PubMed ID: 19201003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.